SCHEMBL13288474

SCHEMBL13288474

N#Cc1ccc(-c2cc(Nc3ccc(Oc4ccc5[nH]ncc5c4)c(F)c3)nc(N)n2)cc1

nearest known ligand 0.79

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 2/20 0.79
ROCK2 O75116 9/20 0.56
CYP3A4 P08684 2/20 0.46
AGPAT2 O15120 3/20 0.43
PIK3CA P42336 2/20 0.42
MAPKAPK2 P49137 1/20 0.41
TNIK Q9UKE5 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
SMO Q99835 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13288472 0.91 ROCK1 (0.72) ROCK1ROCK2CYP3A4AGPAT2PIK3CA
SCHEMBL8328328 0.91 ROCK1 (0.85) ROCK1ROCK2CYP3A4AGPAT2PIK3CA
SCHEMBL13288470 0.89 ROCK1 (0.82) ROCK1ROCK2CYP3A4AGPAT2PIK3CA
SCHEMBL2883920 0.89 ROCK1 (0.85) ROCK1ROCK2CYP3A4AGPAT2PIK3CA
SCHEMBL2880011 0.88 ROCK1 (1.00) ROCK1ROCK2CYP3A4AGPAT2PIK3CA
SCHEMBL8325315 0.87 ROCK1 (0.82) ROCK1ROCK2CYP3A4AGPAT2PIK3CA
SCHEMBL13295007 0.87 ROCK1 (0.79) ROCK1ROCK2CYP3A4AGPAT2PIK3CA
SCHEMBL8322693 0.87 ROCK1 (0.79) ROCK1ROCK2CYP3A4AGPAT2PIK3CA
SCHEMBL8324075 0.85 ROCK1 (0.76) ROCK1ROCK2CYP3A4AGPAT2MAPKAPK2
SCHEMBL8333105 0.85 ROCK1 (0.76) ROCK1ROCK2CYP3A4AGPAT2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737153-B2 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-15 US disclosed
US-7737153-B2 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-15 US disclosed